First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Información del proyecto

PrasinoMed

Identificador del acuerdo de subvención: 827272

DOI

10.3030/827272

Proyecto cerrado

Fecha de la firma de la CE 9 Agosto 2018

Fecha de inicio 1 Agosto 2018

Fecha de finalización 30 Noviembre 2018

Financiado con arreglo a

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Coste total

€ 71 429,00

Aportación de la UE

€ 50 000,00

Coordinado por

PRASINOTECH LTD
United Kingdom

Periodic Reporting for period 1 - PrasinoMed (First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus)

Período documentado: 2018-08-01 hasta 2018-11-30

Resumen del contexto y de los objetivos generales del proyecto

PrasinoTech developed PrasinoSpray, a natural, cost-effective antiviral nasal spray suitable for cold prevention, sustainably manufactured from microalgae. It may also be beneficial for rhinitis suffer
nbavinch ers due to PrasinoMed’s anti-inflammatory properties. The overall objectives of the project are to finalise the formulation and complete a clinical trial to ensure the product is ready for commercial use.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

Using SME Instrument Phase 1 funding, the company carried out a Feasibility Study from August 2018 until November 2018. The study explored both the technical and commercial feasibility of a nasal spray, using microalgae Prasinococcus capsulatus. Throughout the project, the company greatly expanded its knowledge of the business model, requirements for clinical validation and regulatory approval for European market launch.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

Although mortality/morbidity is rare, common colds are responsible for considerable discomfort, absenteeism from school and work, and healthcare costs. The completion of the proposed project will result in a commercial-ready antiviral nasal spray suitable for cold prevention. The polysaccharide elicits effective and superior anti-viral and anti-inflammatory activity compared to other agents. In addition, PrasinoSpray is 100% natural, avoiding adverse effects of chemical compounds

1